Hospital Nossa Senhora da Conceicao   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Tubarão Brazil

Organization Overview

First Clinical Trial
2006
NCT00419081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hospital Nossa Senhora da Conceicao | Hospital Nossa Senhora de Conceicao

Active Ingredients

Drugs in Phase 3 Trials (2)

fentanyl (Innovar) (1 trial)

ketamine (ketalar) (1 trial)

Drugs in Phase 2 Trials (2)

amphotericin b (fungizone) (1 trial)

forodesine (1 trial)

Drugs in Other Trials (2)

norepinephrine (levophed) (1 trial)

vasopressin (vasostrict) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchial Spasm (Phase 3)

Critical Illness (Phase 3)

Histoplasmosis (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6